Post by Novotech

In radiopharmaceutical trials, site feasibility and site readiness are not always the same thing. A key theme from the panel discussion chaired by Stacy Lee, Senior Project Manager, Novotech at the 2026 ARCS Australia Annual Conference was the importance of looking beyond patient access and investigator experience. Successful execution often depends on capabilities that sit behind the scenes, from radiopharmacy access and nuclear medicine infrastructure to imaging capacity, radiation safety processes, and coordination across specialist teams. As radiopharmaceutical development accelerates, sponsors are placing greater emphasis on whether sites can operationalize this complexity, not just recruit patients. If we missed you at ARCS, continue the conversation with a Novotech expert: https://lnkd.in/gC4BDRn9 #ARCS2026 #Radiopharmaceuticals #ClinicalTrials